Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Long-term results of scapulothoracic arthrodesis with multiple cable method for facioscapulohumeral dystrophy.

Erşen A, Atalar AC, Bayram S, Demirel M, Tunalı O, Demirhan M.

Bone Joint J. 2018 Jul;100-B(7):953-956. doi: 10.1302/0301-620X.100B7.BJJ-2017-1438.R1.

PMID:
29954200
2.

Facioscapulohumeral muscular dystrophy.

Tawil R.

Handb Clin Neurol. 2018;148:541-548. doi: 10.1016/B978-0-444-64076-5.00035-1. Review.

PMID:
29478599
3.

FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1.

Park HJ, Lee W, Kim SH, Lee JH, Shin HY, Kim SM, Park KD, Lee JH, Choi YC.

Yonsei Med J. 2018 Mar;59(2):337-340. doi: 10.3349/ymj.2018.59.2.337.

4.

Kinematic analysis of scapular movements in patients with facioscapulohumeral muscular dystrophy.

Savcun Demirci C, Turgut E, Ayvat E, Onursal Ö, Ayvat F, Yıldız TI, Düzgün I, Kılınç M, Aksu Yıldırım S.

J Electromyogr Kinesiol. 2018 Feb;38:88-93. doi: 10.1016/j.jelekin.2017.11.007. Epub 2017 Nov 14.

PMID:
29179028
5.

Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.

Goselink RJM, Voermans NC, Okkersen K, Brouwer OF, Padberg GW, Nikolic A, Tupler R, Dorobek M, Mah JK, van Engelen BGM, Schreuder THA, Erasmus CE.

Neuromuscul Disord. 2017 Dec;27(12):1077-1083. doi: 10.1016/j.nmd.2017.09.007. Epub 2017 Sep 21. Review.

PMID:
29102079
6.

Different profiles of upper limb function in four types of neuromuscular disorders.

Bergsma A, Janssen MMHP, Geurts ACH, Cup EHC, de Groot IJM.

Neuromuscul Disord. 2017 Dec;27(12):1115-1122. doi: 10.1016/j.nmd.2017.09.003. Epub 2017 Sep 15.

PMID:
29033278
7.

Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

Mul K, Vincenten SCC, Voermans NC, Lemmers RJLF, van der Vliet PJ, van der Maarel SM, Padberg GW, Horlings CGC, van Engelen BGM.

Neurology. 2017 Nov 14;89(20):2057-2065. doi: 10.1212/WNL.0000000000004647. Epub 2017 Oct 13.

PMID:
29030457
8.

Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model.

Bosnakovski D, Chan SSK, Recht OO, Hartweck LM, Gustafson CJ, Athman LL, Lowe DA, Kyba M.

Nat Commun. 2017 Sep 15;8(1):550. doi: 10.1038/s41467-017-00730-1. Erratum in: Nat Commun. 2018 Feb 22;9(1):856.

9.

Facioscapulohumeral Muscular Dystrophy.

DeSimone AM, Pakula A, Lek A, Emerson CP Jr.

Compr Physiol. 2017 Sep 12;7(4):1229-1279. doi: 10.1002/cphy.c160039. Review.

PMID:
28915324
10.

Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies.

Hightower RM, Alexander MS.

Muscle Nerve. 2018 Jan;57(1):6-15. doi: 10.1002/mus.25953. Epub 2017 Sep 22. Review.

11.

BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells.

Campbell AE, Oliva J, Yates MP, Zhong JW, Shadle SC, Snider L, Singh N, Tai S, Hiramuki Y, Tawil R, van der Maarel SM, Tapscott SJ, Sverdrup FM.

Skelet Muscle. 2017 Sep 4;7(1):16. doi: 10.1186/s13395-017-0134-x.

12.

Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study.

Fatehi F, Salort-Campana E, Le Troter A, Lareau-Trudel E, Bydder M, Fouré A, Guye M, Bendahan D, Attarian S.

PLoS One. 2017 Aug 25;12(8):e0183825. doi: 10.1371/journal.pone.0183825. eCollection 2017.

13.

Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?

Mammen AL.

Curr Opin Rheumatol. 2017 Nov;29(6):618-622. doi: 10.1097/BOR.0000000000000441. Review.

PMID:
28832350
14.

Ultrasound Imaging of Muscle Contraction of the Tibialis Anterior in Patients with Facioscapulohumeral Dystrophy.

Gijsbertse K, Goselink R, Lassche S, Nillesen M, Sprengers A, Verdonschot N, van Alfen N, de Korte C.

Ultrasound Med Biol. 2017 Nov;43(11):2537-2545. doi: 10.1016/j.ultrasmedbio.2017.06.016. Epub 2017 Jul 29.

PMID:
28764967
15.

Axillary nerve block for a wrist fracture in a patient with facioscapulohumeral (Landouzy-Dejerine) disease.

Mazboudi M, Figueiredo S, Latrech B, Benhamou D.

Anaesth Crit Care Pain Med. 2017 Dec;36(6):409-410. doi: 10.1016/j.accpm.2017.05.004. Epub 2017 Jul 26. No abstract available.

PMID:
28756327
16.

p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy.

Bosnakovski D, Gearhart MD, Toso EA, Recht OO, Cucak A, Jain AK, Barton MC, Kyba M.

Dis Model Mech. 2017 Oct 1;10(10):1211-1216. doi: 10.1242/dmm.030064. Epub 2017 Jul 28.

17.

Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophy.

Nguyen K, Puppo F, Roche S, Gaillard MC, Chaix C, Lagarde A, Pierret M, Vovan C, Olschwang S, Salort-Campana E, Attarian S, Bartoli M, Bernard R, Magdinier F, Levy N.

Hum Mutat. 2017 Oct;38(10):1432-1441. doi: 10.1002/humu.23304. Epub 2017 Aug 6.

18.

Severe Glomerular Endothelial Injury Associated with a Short D4Z4 Repeat on Chromosome 4q35.

Hibino S, Takeda A, Nishino I, Iwata N, Nakano M, Tanaka K, Yamakawa S, Nagai T, Uemura O.

Intern Med. 2017;56(14):1849-1853. doi: 10.2169/internalmedicine.56.7441. Epub 2017 Jul 15.

19.

Surgical correction of hyperlordosis in facioscapulohumeral muscular dystrophy: A case report.

Tan H, Feng F, Lin Y, Chen C, Li Z, Shen J.

BMC Surg. 2017 Jul 17;17(1):83. doi: 10.1186/s12893-017-0276-0.

20.

Are Antioxidants a Potential Therapy for FSHD? A Review of the Literature.

Denny AP, Heather AK.

Oxid Med Cell Longev. 2017;2017:7020295. doi: 10.1155/2017/7020295. Epub 2017 Jun 12. Review.

Supplemental Content

Loading ...
Support Center